Intrinsic Value of S&P & Nasdaq Contact Us

Athenex, Inc. ATNX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
24/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ATNX

Athenex, Inc. (ATNX) has a market capitalization of $2.33M and trades at $0.20. The 52-week range is 0.081-23.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-15.13, annual revenue of $102.82M.

The stock has a beta of 1.35, operates in the Healthcare sector.

Trading Data
Current Price$0.20
52-Week Range0.081-23.8
Volume1.75M
Avg Volume (30D)263.31K
Market Cap$2.33M
Beta (1Y)1.35
Company
IPO Date2017-06-14
Employees269
CEOYiu-Nam Lau F.R.C.P.,
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS04685N1037
CUSIP04685N103
Income (Latest Year)
Revenue$102.82M
Gross Profit$26.7M
EBITDA$-69.57M
Operating Income$-69.94M
Net Income$-98.98M
EPS$-15.13
EPS Diluted$-15.13
Shares Outstanding$6.54M
Balance Sheet (Latest Year)
Total Assets$204.06M
Current Assets$124.93M
Cash & ST Investments$36.69M
Total Liabilities$204.06M
Total Debt$42.36M
Net Debt$6.74M
Total Equity$-24.18M
Debt / Equity-1.75
Valuation Ratios
P/E Ratio-0
P/S Ratio0.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message